Merkel cell carcinoma is a rare and aggressive form of neuroendocrine skin cancer. While it accounts for a small fraction of ...

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their ...

Nodular sclerosis Hodgkin lymphoma is the most common subtype. It often starts in lymph nodes in the chest or neck and is frequently diagnosed in younger adults. Under the microscope, bands of ...

Distinct UV mutational signatures in cutaneous DNA reinforce UV radiation as the predominant environmental carcinogen underlying most skin cancers. Genetic counseling is best targeted to strong ...

Mantras are portrayed as intentional phrases used to align consciousness and cognition toward well-being, clarity, and self-directed goals amid cancer-related stressors. Early mantra work emphasizes ...

Patients with advanced melanoma experienced high response rates when treated with commercial Amtagvi in a real-world clinical ...

FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...

The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Yescarta (axicabtagene ...

Ongoing monitoring remains a cornerstone of survivorship care for patients with cancer, helping detect recurrence early and ...

Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...

Relacorilant plus Abraxane showed benefit without biomarker testing, potentially expanding treatment access for patients with platinum-resistant ovarian cancer.

FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is ...